Global Thalassemia Treatment Market Report By Type (Alpha Thalassemia And Beta Thalassemia), Class (Iron Chelating Drugs And Gene Therapy) End-User (Hospital, Research Institute, Laboratories And Clinics) And By Regions - Industry Trends, Size, Share, Growth, Estimation And Forecast, 2019-2026
ID:VMR11210914
January 2020
Report Formats:

As per this study the Global Thalassemia Treatment Market was valued USD XX.X MN (by revenue) in 2019 and is anticipated to reach USD XX.X MN by 2026 with a CAGR of X.X%.
 
Thalassemia is the genetic blood disease that affects the production of red blood cells (RBCs) and hemoglobin. It can be characterized by pale skin, headache, fatigue, leg cramp, and rapid heartbeats. Thalassemia can be treated by frequent blood transfusion, iron chelation, stem cell transplant, nutritional supplements, and gene therapy.
 
Market Dynamics
 
Rising occurrence of thalassemia with growing awareness to treat thalassemia is driving the market growth. The rise in healthcare expenditure with the growing popularity of gene therapy is further expected to support market growth in the forecast period. Further, rising clinical trails for the development of novel therapies is expected to upsurge the growth of thalassemia treatment market. However, the high cost of the treatment may act as a challenge to market growth.
 
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of thalassemia treatment.
 
Market Segmentation
 
The broad thalassemia treatment market has been sub-grouped into type, class and end-user. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
 
By Type

  • Alpha Thalassemia
  • Beta Thalassemia
 
By Class
  • Iron Chelating Drugs
  • Gene Therapy
 
By End-User
  • Hospital
  • Research Institute
  • Laboratories
  • Clinics
 
Regional Analysis
 
Furthermore, the report comprises of the geographical segmentation, which mainly focuses on current and forecast demand for thalassemia treatment in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
 
Europe Thalassemia Treatment Market By Revenue (USD MN)
 

 
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the thalassemia treatment market include Acceleron Pharma, Inc., Bluebird Bio, Inc., GlaxoSmithKline plc., Incyte Corporation, IONIS Pharmaceuticals, Kiadis Pharma, La Jolla Pharmaceutical Company, Lonza Group Ltd. and Sangamo Bioscience among others. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.
 
 
METHODOLOGY:
 
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Thalassemia Treatment Market
       2.2. Global Thalassemia Treatment Market Snapshot
 
3 . THALASSEMIA TREATMENT – INDUSTRY ANALYSIS
       3.1. Introduction
       3.2. Market Drivers of Thalassemia Treatment Market
       3.3. Market Restraints of Thalassemia Treatment Market
       3.4. Opportunities of Thalassemia Treatment Market
       3.5. Trends of Thalassemia Treatment Market
       3.6. Porter’s Five Force Analysis of Thalassemia Treatment Market
       3.7. Thalassemia Treatment Market Attractiveness Analysis
           3.7.1 Market Attractive Analysis by Type
           3.7.2 Market Attractive Analysis by Class
           3.7.3 Market Attractive Analysis by End-User
           3.7.4 Market Attractive Analysis by Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Thalassemia Treatment Value Chain Analysis
       4.2. Thalassemia Treatment Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Thalassemia Treatment Raw Material Manufactures List
           4.2.3. Price Trend of Thalassemia Treatment Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . GLOBAL THALASSEMIA TREATMENT MARKET ANALYSIS BY TYPE
       5.1 Overview by Type
       5.2 Global Thalassemia Treatment Market Analysis by Type
       5.3 Market Analysis of Alpha Thalassemia by Regions
       5.4 Market Analysis of Beta Thalassemia by Regions
 
6 . GLOBAL THALASSEMIA TREATMENT MARKET ANALYSIS BY CLASS
       6.1 Overview by Class
       6.2 Global Thalassemia Treatment Market Analysis by Class
       6.3 Market Analysis of Iron Chelating Drugs by Regions
       6.4 Market Analysis of Gene Therapy by Regions
 
7 . GLOBAL THALASSEMIA TREATMENT MARKET ANALYSIS BY END-USER
       7.1 Overview by End-User
       7.2 Global Thalassemia Treatment Market Analysis by End-User
       7.3 Market Analysis of Hospital by Regions
       7.4 Market Analysis of Research Institute by Regions
       7.5 Market Analysis of Laboratories by Regions
       7.6 Market Analysis of Clinics by Regions
 
8 . GLOBAL THALASSEMIA TREATMENT MARKET ANALYSIS BY GEOGRAPHY
       8.1. Regional Outlook
       8.2. Introduction
       8.3. North America
           8.3.1. Overview
           8.3.2. North America Thalassemia Treatment Market Estimate by Country
           8.3.3. United State
           8.3.4. Rest of North America
       8.4. Europe
           8.4.1. Overview
           8.4.2. Europe Thalassemia Treatment Market Estimate by Market Segment
           8.4.3. Europe Thalassemia Treatment Market Estimate by Country
           8.4.4. United Kingdom
           8.4.5. France
           8.4.6. Germany
           8.4.7 Rest of Europe
       8.5. Asia Pacific
           8.5.1. Overview
           8.5.2. Asia Pacific Thalassemia Treatment Market Estimate by Market Segment
           8.5.3. Asia Pacific Thalassemia Treatment Market Estimate by Country
           8.5.4. China
           8.5.5. Japan
           8.5.6. India
           8.5.7. Rest of Asia Pacific
       8.6. Latin America
           8.6.1. Overview
           8.6.2. Latin America Thalassemia Treatment Market Estimate by Market Segment
           8.6.3. Latin America Thalassemia Treatment Market Estimate by Country
           8.6.4. Brazil
           8.6.5. Rest of Latin America
       8.7. Middle East & Africa
           8.7.1. Overview
           8.7.2. Middle East & Africa Thalassemia Treatment Market Estimate by Market Segment
           8.7.3. Middle East & Africa Thalassemia Treatment Market Estimate by Country
           8.7.4. Middle East
           8.7.5. Africa
 
9 . COMPETITIVE LANDSCAPE OF THE THALASSEMIA TREATMENT COMPANIES
       9.1. Thalassemia Treatment Market Competition
       9.2. Partnership/Collaboration/Agreement
       9.3. Merger And Acquisitions
       9.4. New Product Launch
       9.5. Other Developments
 
10 . COMPANY PROFILES OF THALASSEMIA TREATMENT INDUSTRY
       10.1. Company Share Analysis
       10.2. Market Concentration Rate
       10.3. Acceleron Pharma, Inc.
           10.3.1. Company Overview
           10.3.2. Financials
           10.3.3. Products
           10.3.4. Recent Developments
       10.4. Bluebird Bio, Inc.
           10.4.1. Company Overview
           10.4.2. Financials
           10.4.3. Products
           10.4.4. Recent Developments
       10.5. GlaxoSmithKline plc.
           10.5.1. Company Overview
           10.5.2. Financials
           10.5.3. Products
           10.5.4. Recent Developments
       10.6. Incyte Corporation
           10.6.1. Company Overview
           10.6.2. Financials
           10.6.3. Products
           10.6.4. Recent Developments
       10.7. IONIS Pharmaceuticals
           10.7.1. Company Overview
           10.7.2. Financials
           10.7.3. Products
           10.7.4. Recent Developments
       10.8. Kiadis Pharma
           10.8.1. Company Overview
           10.8.2. Financials
           10.8.3. Products
           10.8.4. Recent Developments
       10.9. La Jolla Pharmaceutical Company
           10.9.1. Company Overview
           10.9.2. Financials
           10.9.3. Products
           10.9.4. Recent Developments
       10.10. Lonza Group Ltd.
           10.10.1. Company Overview
           10.10.2. Financials
           10.10.3. Products
           10.10.4. Recent Developments
       10.11. Sangamo Bioscience
           10.11.1. Company Overview
           10.11.2. Financials
           10.11.3. Products
           10.11.4. Recent Developments
 
11.  IMPACT ANALYSIS OF COVID-19 OUTBREAK
       11.1. Impact Analysis of Covid-19 Outbreak on the Market
           11.1.1. Direct Impact on Production
           11.1.2. Supply Chain and Market Disruption
           11.1.3. Financial Impact on Firms and Financial Markets
       11.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       11.3. Pre V/S Post COVID-19 Market
       11.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Market Size in 2020, by Scenario
       11.5. COVID-19: Micro and Macro Factor Analysis on the Market
    
 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
LIST OF TABLES

  • Global Market Snapshot
  • Drivers of the Global Market Impact Analysis
  • Restraints of the Global Market Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers 
  • COVID-19 Impact Analysis by Production, Import, Export and Demand
  • Pre V/S Post COVID-19 Market
  • Estimated Impact Of The Coronavirus (Covid-19) Epidemic On The Market Size In 2020, By Scenario
  • COVID-19: Micro and Macro Factor Analysis on the Market
  • Global Thalassemia Treatment Market Analysis by Type (USD MN)
  • Global Thalassemia Treatment Market Analysis in Alpha Thalassemia by Geography (USD MN)
  • Global Thalassemia Treatment Market Analysis in Beta Thalassemia by Geography (USD MN)
  • Global Thalassemia Treatment Market Analysis by Class (USD MN)
  • Global Thalassemia Treatment Market Analysis in Iron Chelating Drugs by Geography (USD MN)
  • Global Thalassemia Treatment Market Analysis in Gene Therapy by Geography (USD MN)
  • Global Thalassemia Treatment Market Analysis by End-User (USD MN)
  • Global Thalassemia Treatment Market Analysis in Hospital by Geography (USD MN)
  • Global Thalassemia Treatment Market Analysis in Research Institute by Geography (USD MN)
  • Global Thalassemia Treatment Market Analysis in Laboratories by Geography (USD MN)
  • Global Thalassemia Treatment Market Analysis in Clinics by Geography (USD MN)
  • Global Thalassemia Treatment Market by Geography (USD MN)
  • North America Thalassemia Treatment Market Analysis by Type (USD MN)
  • North America Thalassemia Treatment Market Estimate by Class (USD MN)
  • North America Thalassemia Treatment Market Estimate by End-User (USD MN)
  • North America Thalassemia Treatment Market Estimate by Country (USD MN)
  • United State Thalassemia Treatment Market Analysis by Type (USD MN)
  • United State Thalassemia Treatment Market Estimate by Class (USD MN)
  • United State Thalassemia Treatment Market Analysis by End-User (USD MN)
  • Rest of North America Thalassemia Treatment Market Analysis by Type (USD MN)
  • Rest of North America Thalassemia Treatment Market Estimate by Class (USD MN)
  • Rest of North America Thalassemia Treatment Market Estimate by End-User(USD MN)
  • Europe Thalassemia Treatment Market Analysis by Type (USD MN)
  • Europe Thalassemia Treatment Market Estimate by Class (USD MN)
  • Europe Thalassemia Treatment Market Estimate by End-User (USD MN)
  • United Kingdom Thalassemia Treatment Market Analysis by Type (USD MN)
  • United Kingdom Thalassemia Treatment Market Estimate by Class (USD MN)
  • United Kingdom Thalassemia Treatment Market Estimate by End-User (USD MN)
  • France Thalassemia Treatment Market Analysis by Type (USD MN)
  • France Thalassemia Treatment Market Estimate by Class (USD MN)
  • France Thalassemia Treatment Market Estimate by End-User (USD MN)
  • Germany Thalassemia Treatment Market Analysis by Type (USD MN)
  • Germany Thalassemia Treatment Market Estimate by Class (USD MN)
  • Germany Thalassemia Treatment Market Estimate by End-User (USD MN)
  • Rest of Europe Thalassemia Treatment Market Analysis by Type (USD MN)
  • Rest of Europe Thalassemia Treatment Market Estimate by Class (USD MN)
  • Rest of Europe Thalassemia Treatment Market Estimate by End-User (USD MN)
  • Asia Pacific Thalassemia Treatment Market Analysis by Type (USD MN)
  • Asia Pacific Thalassemia Treatment Market Estimate by Class (USD MN)
  • Asia Pacific Thalassemia Treatment Market Estimate by End-User (USD MN)
  • Asia Pacific Thalassemia Treatment Market Estimate by Country (USD MN)
  • China Thalassemia Treatment Market Analysis by Type (USD MN)
  • China Thalassemia Treatment Market Estimate by Class (USD MN)
  • China Thalassemia Treatment Market Estimate by End-User (USD MN)
  • Japan Thalassemia Treatment Market Analysis by Type (USD MN)
  • Japan Thalassemia Treatment Market Estimate by Class (USD MN)
  • Japan Thalassemia Treatment Market Estimate by End-User (USD MN)
  • India Thalassemia Treatment Market Analysis by Type (USD MN)
  • India Thalassemia Treatment Market Estimate by Class (USD MN)
  • India Thalassemia Treatment Market Estimate by End-User (USD MN)
  • Rest of Asia Pacific Thalassemia Treatment Market Analysis by Type (USD MN)
  • Rest of Asia Pacific Thalassemia Treatment Market Estimate by Class (USD MN)
  • Rest of Asia Pacific Thalassemia Treatment Market Estimate by End-User (USD MN)
  • Latin America Thalassemia Treatment Market Analysis by Type (USD MN)
  • Latin America Thalassemia Treatment Market Estimate by Class (USD MN)
  • Latin America Thalassemia Treatment Market Estimate by End-User (USD MN)
  • Latin America Thalassemia Treatment Market Estimate by Country (USD MN)
  • Brazil Thalassemia Treatment Market Analysis by Type (USD MN)
  • Brazil Thalassemia Treatment Market Estimate by Class (USD MN)
  • Brazil Thalassemia Treatment Market Estimate by End-User (USD MN)
  • Rest of Latin America Thalassemia Treatment Market Analysis by Type (USD MN)
  • Rest of Latin America Thalassemia Treatment Market Estimate by Class (USD MN)
  • Rest of Latin America Thalassemia Treatment Market Estimate by End-User (USD MN)
  • Middle East & Africa Thalassemia Treatment Market Analysis by Type (USD MN)
  • Middle East & Africa Thalassemia Treatment Market Estimate by Class (USD MN)
  • Middle East & Africa Thalassemia Treatment Market Estimate by End-User (USD MN)
  • Middle East & Africa Thalassemia Treatment Market Estimate by Country (USD MN)
  • Middle East Thalassemia Treatment Market Analysis by Type (USD MN)
  • Middle East Thalassemia Treatment Market Estimate by Class (USD MN)
  • Middle East Thalassemia Treatment Market Estimate by End-User (USD MN)
  • Africa Thalassemia Treatment Market Analysis by Type (USD MN)
  • Africa Thalassemia Treatment Market Estimate by Class (USD MN)
  • Africa Thalassemia Treatment Market Estimate by End-User (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton
  • New Product Launch
  • Other Developments
  • Company Market Share Analysis, 2019
 
LIST OF FIGURES
  • Research Scope of Thalassemia Treatment Report
  • Market Research Process
  • Market Research Methodology
  • Global Thalassemia Treatment Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Type
  • Market Attractiveness Analysis by Class
  • Market Attractiveness Analysis by End-User
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Thalassemia Treatment Market Analysis by Type (USD MN)
  • Global Thalassemia Treatment Market Analysis in Alpha Thalassemia by Geography (USD MN)
  • Global Thalassemia Treatment Market Analysis in Beta Thalassemia by Geography (USD MN)
  • Global Thalassemia Treatment Market Analysis by Class (USD MN)
  • Global Thalassemia Treatment Market Analysis in Iron Chelating Drugs by Geography (USD MN)
  • Global Thalassemia Treatment Market Analysis in Gene Therapy by Geography (USD MN)
  • Global Thalassemia Treatment Market Analysis by End-User (USD MN)
  • Global Thalassemia Treatment Market Analysis in Hospital by Geography (USD MN)
  • Global Thalassemia Treatment Market Analysis in Research Institute by Geography (USD MN)
  • Global Thalassemia Treatment Market Analysis in Laboratories by Geography (USD MN)
  • Global Thalassemia Treatment Market Analysis in Clinics by Geography (USD MN)
  • Latin America Thalassemia Treatment Market by Revenue
  • Middle East & Africa Thalassemia Treatment Market by Revenue
  • Recent Development in Thalassemia Treatment Industry
  • Company Market Share Analysis, 2019
 
 * Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials